373 related articles for article (PubMed ID: 28214020)
1. Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents.
Mosca A; Nobili V; De Vito R; Crudele A; Scorletti E; Villani A; Alisi A; Byrne CD
J Hepatol; 2017 May; 66(5):1031-1036. PubMed ID: 28214020
[TBL] [Abstract][Full Text] [Related]
2. Liver zonation in children with non-alcoholic fatty liver disease: Associations with dietary fructose and uric acid concentrations.
Nobili V; Mosca A; De Vito R; Raponi M; Scorletti E; Byrne CD
Liver Int; 2018 Jun; 38(6):1102-1109. PubMed ID: 29222961
[TBL] [Abstract][Full Text] [Related]
3. The relationship of serum uric acid with non-alcoholic fatty liver disease.
Sertoglu E; Ercin CN; Celebi G; Gurel H; Kayadibi H; Genc H; Kara M; Dogru T
Clin Biochem; 2014 Apr; 47(6):383-8. PubMed ID: 24525254
[TBL] [Abstract][Full Text] [Related]
4. Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).
Fernández Rodríguez CM; Aller R; Gutiérrez García ML; Ampuero J; Gómez-Camarero J; Martín-Mateos RMª; Burgos-Santamaría D; Rosales JM; Aspichueta P; Buque X; Latorre M; Andrade RJ; Hernández-Guerra M; Romero-Gómez M
Rev Esp Enferm Dig; 2019 Apr; 111(4):264-269. PubMed ID: 30810330
[TBL] [Abstract][Full Text] [Related]
5. Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD.
Vos MB; Colvin R; Belt P; Molleston JP; Murray KF; Rosenthal P; Schwimmer JB; Tonascia J; Unalp A; Lavine JE;
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):90-6. PubMed ID: 22197855
[TBL] [Abstract][Full Text] [Related]
6. Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD.
Nobili V; Alisi A; Mosca A; Della Corte C; Veraldi S; De Vito R; De Stefanis C; D'Oria V; Jahnel J; Zohrer E; Scorletti E; Byrne CD
Liver Int; 2018 Feb; 38(2):342-349. PubMed ID: 28746779
[TBL] [Abstract][Full Text] [Related]
7. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
Paschos P; Athyros VG; Tsimperidis A; Katsoula A; Grammatikos N; Giouleme O
Curr Vasc Pharmacol; 2018; 16(3):269-275. PubMed ID: 28676018
[TBL] [Abstract][Full Text] [Related]
8. Oral fructose absorption in obese children with non-alcoholic fatty liver disease.
Sullivan JS; Le MT; Pan Z; Rivard C; Love-Osborne K; Robbins K; Johnson RJ; Sokol RJ; Sundaram SS
Pediatr Obes; 2015 Jun; 10(3):188-95. PubMed ID: 24961681
[TBL] [Abstract][Full Text] [Related]
9. Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease.
Hamza RT; Ahmed AY; Rezk DG; Hamed AI
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1345-1352. PubMed ID: 27442361
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients.
Oral A; Sahin T; Turker F; Kocak E
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31533345
[No Abstract] [Full Text] [Related]
11. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
Petta S; Cammà C; Cabibi D; Di Marco V; Craxì A
Aliment Pharmacol Ther; 2011 Oct; 34(7):757-66. PubMed ID: 21790685
[TBL] [Abstract][Full Text] [Related]
12. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.
Chang EJ; Yi DY; Yang HR
J Korean Med Sci; 2015 Dec; 30(12):1821-7. PubMed ID: 26713058
[TBL] [Abstract][Full Text] [Related]
14. Macronutrient and Micronutrient Intake in Adolescents With Non-alcoholic Fatty Liver Disease: The Association With Disease Severity.
Porto A; Pan Z; Zhou W; Sokol RJ; Klaczkiewicz K; Sundaram SS
J Pediatr Gastroenterol Nutr; 2022 Nov; 75(5):666-674. PubMed ID: 35897136
[TBL] [Abstract][Full Text] [Related]
15. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
Mager DR; Iñiguez IR; Gilmour S; Yap J
JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
[TBL] [Abstract][Full Text] [Related]
16. The relationship between excessive dietary fructose consumption and paediatric fatty liver disease.
DiStefano JK; Shaibi GQ
Pediatr Obes; 2021 Jun; 16(6):e12759. PubMed ID: 33305889
[TBL] [Abstract][Full Text] [Related]
17. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
Nier A; Brandt A; Conzelmann IB; Özel Y; Bergheim I
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235828
[TBL] [Abstract][Full Text] [Related]
18. High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity.
Di Bonito P; Valerio G; Licenziati MR; Miraglia Del Giudice E; Baroni MG; Morandi A; Maffeis C; Campana G; Spreghini MR; Di Sessa A; Morino G; Crinò A; Chiesa C; Pacifico L; Manco M
J Endocrinol Invest; 2020 Apr; 43(4):461-468. PubMed ID: 31637675
[TBL] [Abstract][Full Text] [Related]
19. Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review.
Caliceti C; Calabria D; Roda A; Cicero AFG
Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420204
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.
Peng L; Wu S; Zhou N; Zhu S; Liu Q; Li X
BMC Pediatr; 2021 Mar; 21(1):122. PubMed ID: 33711964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
